Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Am J Transplant ; 14(10): 2275-87, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25220221

ABSTRACT

The generation of pigs with genetic modifications has significantly advanced the field of xenotransplantation. New genetically engineered pigs were produced on an α1,3-galactosyltransferase gene-knockout background with ubiquitous expression of human CD46, with islet beta cell-specific expression of human tissue factor pathway inhibitor and/or human CD39 and/or porcine CTLA4-lg. Isolated islets from pigs with 3, 4 or 5 genetic modifications were transplanted intraportally into streptozotocin-diabetic, immunosuppressed cynomolgus monkeys (n = 5). Immunosuppression was based on anti-CD154 mAb costimulation blockade. Monitoring included features of early islet destruction, glycemia, exogenous insulin requirement and histopathology of the islets at necropsy. Using these modified pig islets, there was evidence of reduced islet destruction in the first hours after transplantation, compared with two series of historical controls that received identical therapy but were transplanted with islets from pigs with either no or only one genetic modification. Despite encouraging effects on early islet loss, these multi-transgenic islet grafts did not demonstrate consistency in regard to long-term success, with only two of five demonstrating function beyond 5 months.


Subject(s)
Islets of Langerhans Transplantation , Transplantation, Heterologous , Animals , Animals, Genetically Modified , Blood Glucose/analysis , CTLA-4 Antigen/immunology , Female , Glucose/administration & dosage , Immunosuppressive Agents/administration & dosage , Liver/pathology , Macaca fascicularis , Membrane Cofactor Protein/immunology , Pancreas/pathology , Swine
2.
Transpl Immunol ; 29(1-4): 88-98, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24120957

ABSTRACT

Repopulation of memory T cells (Tmem) in allograft recipients after lymphodepletion is a major barrier to transplant tolerance induction. Ineffective depletion of naïve T cells (Tn) and Tmem may predispose to repopulation of Tmem after transplantation. Cynomolgus macaque monkeys given heart allografts were lymphodepleted using Alemtuzumab (Campath-1H; anti-CD52). Peripheral blood (PB) and lymph nodes (LN) were analyzed for CD95(-) (Tn) and CD95(+) cells (Tmem), one day, one month and up to three months after Alemtuzumab infusion. CD52 expression, susceptibility to Alemtuzumab cytotoxicity and pro-apoptotic caspase-3 were evaluated in Tn and Tmem. In vivo, Alemtuzumab induction profoundly depleted lymphocytes in PB (99% reduction) but exerted a lesser effect in LN (70% reduction), with similar depletion of Tn and Tmem subsets. After transplantation, Tmem comprised the majority of lymphocytes in PB and LN. In vitro, LN T cells were more resistant to Alemtuzumab-mediated cytotoxicity than PB lymphocytes. CD4(+) Tn and Tmem were equally susceptible to Alemtuzumab-mediated cytotoxicity, whereas CD8(+) Tn were more resistant than CD8(+) Tmem. However, no significant differences in CD52 expression between lymphocyte subsets in PB and LN were observed. Caspase-3 expression was higher in PB than LN T cells. CD4(+) and CD8(+) Tn expressed lower levels of Caspase-3 than Tmem, in both PB and LN. Thus, after Alemtuzumab infusion, residual Tn in secondary lymphoid tissue may predispose to rapid recovery of Tmem in allograft recipients.


Subject(s)
Antibodies, Monoclonal, Humanized/pharmacology , Antineoplastic Agents/pharmacology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Heart Transplantation , Lymphocyte Depletion , Lymphoid Tissue/immunology , Memory, Short-Term/drug effects , Alemtuzumab , Allografts , Animals , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/pathology , Caspase 3/immunology , Lymphoid Tissue/pathology , Macaca fascicularis , fas Receptor/immunology
3.
Am J Transplant ; 10(4): 773-783, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20420638

ABSTRACT

As the target CD52 molecule is expressed on erythrocytes of most nonhuman primate strains, using alemtuzumab in these species would cause massive hemolysis. Six cynomolgus monkeys of Indonesian origin, screened by agglutination assay for absence of CD52 on erythrocytes, were administered alemtuzumab in a cumulative dose to a maximum of 60 mg/kg. In two monkeys, mycophenolate mofetil (MMF) was added as maintenance therapy. Complete depletion of T and B lymphocytes (>99.5%) was achieved with 20 mg/kg alemtuzumab and was more profound than in monkeys treated with antithymocyte globulin (n = 5), as quantified by flow cytometry. Repopulation was suppressed by weekly injections of 10 mg/kg. Without MMF, repopulation of CD20(+)B cells and CD8(+)T cells was complete within 2 and 3 months, respectively, and repopulation of CD4(+)T cells was 67% after 1 year. MMF significantly delayed CD4(+)T-cell repopulation. Among repopulating CD4(+) and CD8(+) T cells, a phenotypic shift was observed from CD45RA(hi)CD62L(hi) naïve cells toward CD45RA(lo)CD62L(lo) effector memory cells. In lymph nodes, the depletion of naïve cells was more profound than of memory cells, which may have initiated a proliferation of memory cells. This model offers opportunities to investigate lymphocyte depletion/repopulation phenomena, as well as the efficacy of alemtuzumab in preclinical transplantation models.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antibodies, Neoplasm/therapeutic use , Cell Division/drug effects , Lymphocyte Depletion , Lymphocytes/cytology , Alemtuzumab , Animals , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal, Humanized , Antibodies, Neoplasm/pharmacology , Antigens, CD/immunology , Flow Cytometry , Immunophenotyping , Lymphocytes/immunology , Macaca fascicularis
4.
Dig Surg ; 27(1): 61-7, 2010.
Article in English | MEDLINE | ID: mdl-20357453

ABSTRACT

BACKGROUND: The diagnosis of hepatocellular adenoma (HA) has a great impact on the lives of young women and may pose clinical dilemmas to the clinician since there are no standardized protocols to follow. We aimed to establish expert opinions on diagnosis and treatment of HA by collecting data from a nationwide questionnaire in the Netherlands. METHODS: A questionnaire was sent to 20 Dutch hospitals known to offer hepatologic and surgical experience on liver tumours. RESULTS: 17 hospitals (85%) responded to the questionnaire. Annually, a median of 52 patients presented with a solid liver tumour. In 15 (88%) hospitals, hepatic adenomas were diagnosed with contrast-enhanced, multiphase spiral CT or MRI. In 2 (12%) hospitals, histology was required as part of a management protocol. Surveillance after withdrawal of oral contraceptives was the initial policy in all clinics. MRI, CT or ultrasound was used for follow-up. Criteria for surgical resection were a tumour size >5 cm and abdominal complaints. In 5 (29%) hospitals, patients were dismissed from follow-up after surgery. In complex cases (e.g. large, multiple or centrally localized lesions, a wish for pregnancy), the treatment policy was highly variable. Pregnancy was not discouraged in 15 hospitals, but in 11 (65%) of these, strictly defined conditions were noted: frequent follow-up, peripheral tumour localization that makes surgery easier if necessary, stable tumour size, and a good informed consent. CONCLUSION: The management of HAs in the Netherlands is rather uniform, except in complex cases in which multiple factors may influence policy.


Subject(s)
Adenoma, Liver Cell/diagnosis , Adenoma, Liver Cell/surgery , Liver Neoplasms/diagnosis , Liver Neoplasms/surgery , Female , Follow-Up Studies , Humans , Netherlands , Pregnancy , Surveys and Questionnaires
5.
Am J Transplant ; 9(12): 2716-26, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19845582

ABSTRACT

Xenotransplantation of porcine islets into diabetic non-human primates is characterized by (i) an initial massive graft loss possibly due to the instant blood-mediated inflammatory reaction and (ii) the requirement of intensive, clinically unfriendly immunosuppressive therapy. We investigated whether the transgenic expression of a human complement-regulatory protein (hCD46) on porcine islets would improve the outcome of islet xenotransplantation in streptozotocin-induced diabetic Cynomolgus monkeys. Immunosuppression consisted of thymoglobulin, anti-CD154 mAb for costimulation blockade, and mycophenolate mofetil. Following the transplantation of islets from wild-type pigs (n = 2) or from 1,3-galactosyltransferase gene-knockout pigs (n = 2), islets survived for a maximum of only 46 days, as evidenced by return to hyperglycemia and the need for exogenous insulin therapy. The transplantation of islets from hCD46 pigs resulted in graft survival and insulin-independent normoglycemia in four of five monkeys for the 3 months follow-up of the experiment. One normalized recipient, selected at random, was followed for >12 months. Inhibition of complement activation by the expression of hCD46 on the pig islets did not substantially reduce the initial loss of islet mass, rather was effective in limiting antibody-mediated rejection. This resulted in a reduced need for immunosuppression to preserve a sufficient islet mass to maintain normoglycemia long-term.


Subject(s)
Blood Glucose/metabolism , Diabetes Mellitus, Experimental/physiopathology , Islets of Langerhans Transplantation/methods , Membrane Cofactor Protein/genetics , Transplantation, Heterologous , Animals , Animals, Genetically Modified , Diabetes Mellitus, Experimental/surgery , Female , Macaca fascicularis , Male , Swine
6.
Am J Transplant ; 9(11): 2485-96, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19775318

ABSTRACT

The results of transplantation of human donor islets into the portal vein (PV) in patients with diabetes are encouraging. However, there are complications, for example, hemorrhage, thrombosis and an immediate loss of islets through the 'instant blood-mediated inflammatory reaction' (IBMIR). The gastric submucosal space (GSMS) offers potential advantages. Islets were isolated from adult pigs. Recipient pigs were made diabetic by streptozotocin. Donor islets were injected into the GSMS through a laparotomy (Group 1A, n = 4) or endoscopically (Group 1B, n = 8) or into the PV through a laparotomy (Group 2, n = 3). The pigs were followed for a maximum of 28 days. Monitoring of C-peptide in Group 1 indicated that there was minimal immediate loss of islets whereas in Group 2 there was considerable loss from IBMIR. In Group 1, there were significant reductions in mean blood glucose and mean exogenous insulin requirement between pretransplantation and 20 days posttransplantation. In Group 2, there was no significant reduction in either parameter. Insulin-positive cells were seen in the GSMS in Group 1, but not in the liver in Group 2. Endoscopic gastric submucosal transplantation of islets (ENDO-STI) offers a minimally invasive and quick approach to islet transplantation, avoids IBMIR and warrants further exploration.


Subject(s)
Diabetes Mellitus, Experimental/surgery , Endoscopy/methods , Gastric Mucosa/surgery , Islets of Langerhans Transplantation/methods , Animals , Blood Glucose/metabolism , C-Peptide/blood , Combined Modality Therapy , Diabetes Mellitus, Experimental/drug therapy , Female , Graft Rejection/drug therapy , Graft Rejection/immunology , Graft Rejection/pathology , Graft Survival , Hypoglycemic Agents/pharmacology , Immunosuppressive Agents/pharmacology , Insulin/pharmacology , Islets of Langerhans Transplantation/immunology , Mycophenolic Acid/analogs & derivatives , Mycophenolic Acid/pharmacology , Pancreatectomy , Sus scrofa , Tacrolimus/pharmacology , Transplantation, Homologous
7.
Diabetologia ; 51(1): 120-9, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17960359

ABSTRACT

AIMS/HYPOTHESIS: Attempts to use an alternative source of islets to restore glucose homeostasis in diabetic patients require preclinical islet xenotransplantation models to be tested. These models raise questions about metabolic compatibility between species and the most appropriate metabolic parameters to be used to monitor graft function. The present study investigated and compared relevant gluco-metabolic parameters in pigs, monkeys and the pig-to-monkey islet transplantation model to gain insight into the potential clinical outcome of pig-to-human islet transplantation. METHODS: Basal and IVGTT-stimulated blood glucose, C-peptide, insulin and glucagon levels were assessed in non-diabetic pigs and monkeys. The same parameters were used to evaluate the performance of porcine islet xenografts in diabetic monkeys. RESULTS: Non-diabetic cynomolgus monkeys showed lower levels of fasting and stimulated blood glucose but higher levels of C-peptide and insulin than non-diabetic pigs. The reported levels in humans lie between those of monkeys and pigs, and differences in metabolic parameters between pigs and humans appear to be smaller than those between pigs and cynomolgus monkeys. The transplantation data indicated that the degree of graft function (evaluated by the measurement of C-peptide levels) necessary to normalise blood glucose in the recipient was determined by the recipient levels rather than by the donor levels. CONCLUSIONS/INTERPRETATION: The differences between donor and recipient species may affect the transplantation outcome and need to be considered when assessing graft function in xenotransplantation models. Given the differences between monkeys and humans as potential recipients of pig islets, it should be easier to reach glucose homeostasis in pig-to-human than in pig-to-non-human primate islet xenotransplantation.


Subject(s)
Islets of Langerhans Transplantation/methods , Transplantation, Heterologous/methods , Animals , Blood Glucose/metabolism , C-Peptide/blood , Diabetes Mellitus, Experimental/blood , Female , Glucagon/blood , Insulin/metabolism , Macaca fascicularis , Male , Metabolism , Sus scrofa , Time Factors , Treatment Outcome
8.
Ned Tijdschr Geneeskd ; 151(24): 1345-51, 2007 Jun 16.
Article in Dutch | MEDLINE | ID: mdl-17665627

ABSTRACT

OBJECTIVE: To establish the current expert opinions on the diagnosis and treatment of hepatocellular adenoma in the Netherlands. DESIGN: Questionnaire. METHOD: In 2005, a questionnaire concerning the incidence, diagnosis, treatment, management in case of pregnancy, and follow-up of hepatocellular adenoma was sent to 20 Dutch hospitals with a tertiary referral role. In addition, they were asked to describe the indicated treatment in 5 imaginary cases. RESULTS: 17 hospitals (85%) responded. A median of 52 patients per hospital presented with a solid liver tumour annually. Between 1 and 40% of these patients had benign lesions with a differential diagnosis of adenoma, focal nodular hyperplasia, and haemangioma. In 15 clinics (88%), hepatic adenomas were diagnosed with contrast-enhanced, multiphasic, spiral CT or MRI series. 2 clinics (12%) required a histological diagnosis. Conservative management (withdrawal of oral contraceptives and radiological control) was initially given in all clinics. MRI, CT or ultrasound were used to follow adenoma patients with different time schedules. The criteria for surgical resection were a tumour size > 5 cm and abdominal complaints. In 5 clinics (29%), the patients were no longer followed after surgery. In cases in which multiple factors played a role (size, location, number of lesions, and wish to become pregnant), the treatment policy was highly variable. Pregnancy was not discouraged in 15 clinics, but in 11 (65%) only under strict conditions: frequent control, a peripheral location that makes surgery possible if necessary, a stable tumour size, and an understanding of the risks. CONCLUSION: The management of hepatocellular adenomas in the Netherlands is rather uniform, except for differences in the methods of observation and the treatment policy in cases in which multiple factors play a role.


Subject(s)
Adenoma, Liver Cell/diagnosis , Contraceptives, Oral/adverse effects , Liver Neoplasms/diagnosis , Practice Patterns, Physicians' , Adenoma, Liver Cell/surgery , Adenoma, Liver Cell/therapy , Contraceptives, Oral/administration & dosage , Diagnosis, Differential , Female , Humans , Liver Neoplasms/surgery , Liver Neoplasms/therapy , Male , Netherlands , Practice Patterns, Physicians'/statistics & numerical data , Pregnancy , Surveys and Questionnaires
9.
Br J Surg ; 93(12): 1495-502, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17051603

ABSTRACT

BACKGROUND: Treatment of suspected hepatocellular adenoma (HA) remains controversial. The aim of this study was to evaluate the management of HA at a time when magnetic resonance imaging (MRI) and computed tomography (CT) are highly sensitive methods for diagnosing HA. METHODS: Between January 2000 and January 2005, data from 48 consecutive women with HA (median age 36 years) were prospectively collected. The protocol for diagnostic work-up consisted of multiphasic MRI or CT. Management was observation if the tumour was smaller than 5 cm and surgical intervention if it was 5 cm or larger. RESULTS: The median follow-up was 24 (range 3-73) months. Sixteen (33 per cent) patients had invasive procedures because of tumour size 5 cm or larger, malignant characteristics or haemorrhage. The remaining 32 patients (67 per cent) were observed; haemorrhage and malignant degeneration did not occur and none of the lesions showed enlargement after withdrawal of oral contraceptives. Multiple HAs were found in 32 (67 per cent) patients; liver steatosis was significantly more common in these patients than in those with a solitary lesion (59 versus 19 per cent; P = 0.008). CONCLUSION: Observation of adenomas smaller than 5 cm is justified because of improved radiological reliability. Resection should be reserved for patients with malignant tumour characteristics or with single lesions 5 cm or larger.


Subject(s)
Adenoma, Liver Cell/diagnosis , Liver Neoplasms/diagnosis , Tomography, X-Ray Computed , Adenoma, Liver Cell/chemically induced , Adenoma, Liver Cell/surgery , Adult , Contraceptives, Oral/administration & dosage , Contraceptives, Oral/adverse effects , Female , Follow-Up Studies , Hepatectomy/methods , Humans , Liver Neoplasms/chemically induced , Liver Neoplasms/surgery , Magnetic Resonance Imaging , Middle Aged , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...